Showing results (1-10 of 88) with videos related to

Sort By:
Pageof 9
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 11, 2013
Aprepitant versus dexamethasone for preventing chemotherapy-induced delayed emesis in patients with breast cancer: a randomized double-blind studyFausto Roila, Benedetta Ruggeri, Enzo Ballatori, et al.
Tumori|April 26, 2007
Is there still a role for the uniscale assessment of quality of life?Enzo Ballatori, Giampiero Porzio, Fausto Roila, et al.
Assistenza Infermieristica E Ricerca : AIR|July 9, 2014
[Update on anticancer drugs]Fausto Roila, Enzo Ballatori
Tumori|March 15, 2008
Inappropriate doses of chemotherapy in Italian breast cancer patients enrolled in clinical trialsEnzo Ballatori, Fausto Roila, Benedetta Ruggeri, et al.
Health and Quality of Life Outcomes|October 3, 2003
Impact of nausea and vomiting on quality of life in cancer patients during chemotherapyEnzo Ballatori, Fausto Roila
BMJ Open|July 2, 2018
Conflict of interest among Italian medical oncologists: a national surveyAndrea DeCensi, Gianmauro Numico, Enzo Ballatori, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 31, 2006
The impact of chemotherapy-induced nausea and vomiting on health-related quality of lifeEnzo Ballatori, Fausto Roila, Benedetta Ruggeri, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 22, 2006
The cost of chemotherapy-induced nausea and vomiting in ItalyEnzo Ballatori, Fausto Roila, Benedetta Ruggeri, et al.
Tumori|March 10, 2010
Off-label prescription of antineoplastic drugs: an Italian prospective, observational, multicenter surveyFausto Roila, Enzo Ballatori, Roberto Labianca, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 12, 2016
2016 updated MASCC/ESMO consensus recommendations: Prevention of nausea and vomiting following moderately emetogenic chemotherapyFausto Roila, David Warr, Paul J Hesketh, et al.
Pageof 9